ERBB2 and breast carcinoma: To directly evaluate whether CD9 and HER2 molecules were co-expressed on the same EVs, we performed super-resolution microscopy (dSTORM imaging) of EVs derived from HER2+SKBR-3 compared to HER2negMDA-MB-231 breast cancer cells.